๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Zhengzhou
Clinical trial register · China

Clinical Trials in Zhengzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Henan Cancer Hospital72 The First Affiliated Hospital of Zhengzhou University39 Merck Sharp & Dohme LLC27 AbbVie21 Novartis Pharmaceuticals20
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Zhengzhou

921 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
NCT07751003COPD (Chronic Obstructive Pulmonary Disease), Acute Exacerbation of COPD, Hypercapnia
Sir Run Run Shaw Hospital
Not applicable
236
Zhengzhou, Changsha, Hangzhou, Wenling
2027-08-01
Not yet open
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
NCT07441408Pulmonary Fibrosis
Bristol-Myers Squibb
Phase 3
2,380
Hefei, Beijing, Shenzhen, Guangzhou, Shenzhen Shi, Zhengzhou, Shijiazhuang, Yichang Shi
2026-12-16
Not yet open
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
NCT07725484Heart Failure Due to Coronary Artery Disease
Shanghai Zhongshan Hospital
Phase 3
1,526
Hefei, Fuzhou, Guangzhou, Luoyang, Zhengzhou, Nanjing, Dalian, Xi'an
2026-11-01
Not yet open
Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer
NCT07781150Obesity, Overweight, Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I
Tongji Hospital
Phase 2
128
Zhengzhou, Wuhan, Changchun, Hangzhou, Shanghai, Tianjin
2026-11-01
Not yet open
A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ Adenocarcinoma
NCT07828873Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital of Zhengzhou University
Phase 2
34
Zhengzhou
2026-11
Not yet open
A Multicenter, Randomized, Open-Label, Positive Controlled Phase III Study to Evaluate the Efficacy and Safety of VSA012 Injection in Participants With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy
NCT07816237Paroxysmal Nocturnal Hemoglobinuria, PNH
Bisirna Therapeutics (Suzhou) Co., Ltd.
Phase 3
70
Beijing, Jilin City, Quanzhou, Guangzhou, Nanning, Harbin, Zhengzhou, Wuhan
2026-10-29
Not yet open
A Phase 3 Study to Compare the Efficacy of ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r/r MCL).
NCT07784101Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3
280
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan
2026-10
Not yet open
Trastuzumab Combined With Retlirafusp Alfa in Treating HER2๏ผˆHuman Epidermal Growth Factor Receptor 2๏ผ‰ 2+/3+ Gastric/Gastroesophageal Junction Adenocarcinoma After First-line Systemic Therapy Failure
NCT07817654GC, GEJC
Henan Cancer Hospital
Phase 2
35
Zhengzhou
2026-09-30
Recruiting
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
NCT07412704Arthritis, Rheumatoid
Bristol-Myers Squibb
Phase 1/2
84
Beijing, Guangzhou, Zhengzhou, Nanchang, Shanghai
2026-09-15
Not yet open
A Trial of Inebilizumab in Participants With Autoimmune Hepatitis
NCT07598825Autoimmune Hepatitis, AIH
Amgen
Phase 3
180
Hefei, Beijing, Zhengzhou, Shanghai
2026-09-07
Recruiting
A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell Carcinoma
NCT07751341Advanced Esophageal Squamous Cell Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
84
Beijing, Zhengzhou
2026-09-07
Not yet open
Study of SG301 for Renal AMR After Transplantation
NCT07764627Antibody Mediated Rejection
Hangzhou Sumgen Biotech Co., Ltd.
Phase 2
10
Guangzhou, Nanning, Zhengzhou, Changsha, Jinan, Chengdu, Hangzhou
2026-09-01
Not yet open
PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke
NCT07466251Acute Ischemic Stroke AIS, Intracranial Atherosclerosis ICAS, Atherosclerotic Plaque
Peking Union Medical College Hospital
Phase 4
1,212
Beijing, Meizhou, Cangzhou, Qinhuangdao, Shijiazhuang, Tangshan, Harbin, Zhengzhou
2026-09-01
Not yet open
Rituximab, Pirtobrutinib, Lisaftoclax and Liposomal Mitoxantrone for for Richter Syndrome Transformed From CLL
NCT07831395Richter Syndrome
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
23
Zhengzhou, Changsha, Nanchang, Guangzhou, Nanjing, Wuhan
2026-09-01
Not yet open
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
NCT07732309Systemic Lupus Erythematosus, Systemic Sclerosis (SSc), Sjogren's Disease, Autoimmune Diseases
Antengene Biologics Limited
Phase 1
149
Bengbu, Hefei, Beijing, Xiamen, Guangzhou, Luoyang, Zhengzhou, Wuhan
2026-09-01
Not yet open
A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention
NCT07798284Overweight/Obesity
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
80
Beijing, Guangzhou, Zhengzhou, Wuhan, Xianning, Jinan, Shanghai, Luzhou
2026-09
Not yet open
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
NCT07678593Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS Mutation
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
222
Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Shenyang, Xi'an, Jinan
2026-09
Not yet open
Yiqi Fumai Lyophilized Injection for Chronic Heart Failure Caused by Coronary Heart Disease
NCT07803471Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Coronary Heart Disease (CHD)
China Academy of Chinese Medical Sciences
Not applicable
100
Guangzhou, Zhengzhou, Jinan, Tianjin
2026-09
Not yet open
Standardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma
NCT07769658Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University
Observational
500
Guangzhou, Zhengzhou, Shanghai, Chengdu, Tianjin, Kunming
2026-09
Not yet open
Retlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer
NCT07814859Pancreatic Cancer
The First Affiliated Hospital of Zhengzhou University
Phase 2
88
Zhengzhou
2026-08-31
Recruiting
Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration
NCT07776522Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
West China Hospital
Phase 2
50
Beijing, Jilin City, Chongqing, Shantou, Zhejiang, Harbin, Zhengzhou, Wuhan
2026-08-31
Not yet open
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion
NCT07790419Liver Cancer
Zhai Wenlong
Phase 4
40
Zhengzhou
2026-08-30
Not yet open
Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases
NCT07745257HR-positive, HER2-negative Metastatic Breast Cancer With Brain Metastases
Sun Yat-sen University
Phase 2
40
Guangzhou, Shijiazhuang, Anyang, Zhengzhou, Nanjing, Nanchang, Dalian, Chengdu
2026-08-28
Recruiting
A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors
NCT07730190Advanced Malignancies
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1
145
Hefei, Beijing, Fuzhou, Guangzhou, Harbin, Zhengzhou, Changsha, Shanghai
2026-08-25
Not yet open
VBC117First-in-Human Trial of VBC117 in Participants With Advanced Malignant Solid Tumors
NCT07772934Advanced Solid Tumors
VelaVigo Bio Inc
Phase 1/2
260
Zhejiang, Zhengzhou, Changsha, Nanchang, Shengyang, Shanghai, Taiyuan
2026-08-24
Not yet open
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
NCT07720193Advanced Extrapulmonary Neuroendocrine Carcinoma
Nanjing Leads Biolabs Co.,Ltd
Phase 3
280
Beijing, Fuzhou, Lanzhou, Guangzhou, Nanning, Harbin, Luoyang, Zhengzhou
2026-08-22
Not yet open
A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy
NCT07572812Epilepsy
Shanghai UniXell Biotechnology Co., Ltd
Phase 1
12
Beijing, Zhengzhou, Chengdu
2026-08-20
Not yet open
TCM Cohort for Elderly COPD
NCT07780682Chronic Obstructive Pulmonary Disease (COPD)
Henan University of Traditional Chinese Medicine
Observational
2,386
Zhengzhou
2026-08-20
Not yet open
TCM Cohort for Elderly CAP
NCT07797686Community-acquired Pneumonia (CAP)
Henan University of Traditional Chinese Medicine
Observational
2,234
Zhengzhou
2026-08-20
Not yet open
A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy
NCT07752264Refractory Immune-mediated Necrotizing Myopathy
Nanjing IASO Biotechnology Co., Ltd.
Phase 1/2
27
Beijing, Zhengzhou, Shanghai, Hangzhou
2026-08-15
Recruiting
A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis
NCT07660848Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
160
Beijing, Zhengzhou
2026-08-14
Recruiting
Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis
NCT07678931Seasonal Allergic Rhinitis (SAR)
Chengdu Kangnuoxing Biopharma,Inc.
Phase 3
136
Beijing, Langfang, Baoding, Cangzhou, Shijiazhuang, Zhangjiakou, Zhengzhou, Baotou
2026-08-13
Not yet open
Phase โ…ข Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
NCT07741045Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset
Hangzhou PhecdaMed Co., Ltd.
Phase 3
300
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2026-08-03
Not yet open
Evaluation of NWRD09 for HPV-16 Related Cervical HSIL
NCT07712692High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd.
Phase 2
156
Beijing, Chongqing, Lanzhou, Baoding, Zhengzhou, Nanjing, Changchun, Jinan
2026-08-01
Not yet open
Systemic Traditional Chinese Medicine in Multidrug-Resistant Bacterial Pneumonia
NCT07726095Multi Drug Resistant Infections, Pneumnia
Henan University of Traditional Chinese Medicine
Observational
528
Zhengzhou
2026-08-01
Not yet open
The Impact of Multimodal Brain Monitoring on Postoperative Outcomes in Elderly Patients Undergoing Major Abdominal Surgery
NCT07713355Anesthesia, General, Major Abdominal Surgeries
Xuanwu Hospital, Beijing
Not applicable
368
Beijing, Zhengzhou, Wuhan
2026-08-01
Not yet open
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis
NCT07765524Primary Light Chain (AL) Amyloidosis
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase 1/2
32
Guangzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Jinan, Shanghai, Chengdu
2026-08
Recruiting
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
NCT07424833Relapsed/Refractory Hematological Malignancies, Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL, Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation), Relapsed/Refractory Mantle Cell Lymphoma (MCL)
Ascentage Pharma Group Inc.
Phase 1
180
Zhengzhou
2026-08
Not yet open
A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT07753369Small Lymphocytic Lymppho, Relapsed/Refractory Chronic Lymphocytic Leukemia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
128
Zhengzhou, Nanjing
2026-08
Not yet open
Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellviยฎ
NCT07663526Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 4
50
Fuyang, Zhengzhou, Zhoukou, Huaian, Yancheng, Meihekou, Shanghai
2026-08
Recruiting
Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
NCT07733830Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
120
Beijing, Zhengzhou, Shenyang, Taiyuan, Chengdu, Tianjin
2026-07-31
Recruiting
A Prospective, Open-Label, Randomized Controlled Clinical Study Comparing Hepatic Arterial Infusion Chemotherapy (HAIC) With Capecitabine as Adjuvant Therapy After Radical Surgery for Malignant Biliary Tract Tumors
NCT07790445Malignant Biliary Tract Tumors
Zhai Wenlong
Phase 4
90
Zhengzhou
2026-07-30
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
NCT07670884Chronic Management of Body Weight
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
675
Zhengzhou, Nanjing
2026-07-24
Recruiting
A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions
NCT07790562Iron Deficiency Anemia
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1
88
Zhengzhou
2026-07-23
Recruiting
A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy
NCT07559786SCLC, Limited Stage
Henan Cancer Hospital
Phase 2
200
Zhengzhou
2026-07-17
Not yet open
SMP-656 for HER2-Positive Advanced Breast Cancer
NCT07726342HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)
Chengdu SciMount Pharmatech Co., Ltd.
Phase 2
60
Hefei, Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Changsha, Nanjing
2026-07-16
Recruiting
PEI-GT Trial for Initial Treatment of Primary Open-Angle Glaucoma With Cataract
NCT07700498Primary Open Angle Glaucoma and Cataracts
Nanfang Hospital, Southern Medical University
Not applicable
106
Ningxia, Guangzhou, Luzhou, Zhengzhou, Zhuhai
2026-07-15
Recruiting
Polypills Approach for Multiple Cardiovascular Risk Factors
NCT07679828Hypertension, Dyslipidemia, Diabetes
China Medical University, China
Not applicable
8,252
Zhengzhou, Chifeng, Tongliao, Kunshan, Suzhou, Taizhou, Jinzhou, Panjin
2026-07-11
Not yet open
Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Mature B-cell Lymphoma
NCT07459608Indolent Lymphoma, WM, MZL, CLL / SLL
Henan Cancer Hospital
Phase 2
75
Zhengzhou
2026-07-10
Recruiting
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
NCT07538804Non-Small Cell Lung Cancer
Avistone Biotechnology Co., Ltd.
Phase 1/2
294
Guangzhou, Harbin, Zhengzhou, Chengdu
2026-07-10
Recruiting
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
NCT07600788Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Phase 1
32
Chongqing, Zhengzhou, Shanghai, Chengdu, Hangzhou
2026-07-09
Recruiting
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
NCT07670416Obesity, Overweight, Type 2 Diabetes Mellitus (T2DM)
Hoffmann-La Roche
Phase 3
300
Zhengzhou, Xianyang, Ningbo, Beijing, Changchun, Hefei, Herbin, Huai'an
2026-07-03
Recruiting
A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
NCT07660432Neoplasms, Malignant
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
472
Fuzhou, Zhengzhou, Changsha, Shenyang, Jinan, Hangzhou
2026-07-03
Recruiting
A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers
NCT07738991Healthy Participants
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Phase 1
202
Zhengzhou
2026-07-03
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
NCT07476287Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer, Lung Neoplasms
Pfizer
Phase 2
40
Beijing, Fuzhou, Zhengzhou, Wuhan, Nanchang, Shanghai
2026-07-02
Not yet open
Zishen Yutai Pill for Patients With Recurrent Implantation Failure
NCT07641088Recurrent Implantation Failure
Peking University Third Hospital
Not applicable
878
Hefei, Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Changsha, Nanjing, Xi'an
2026-07-01
Not yet open
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
NCT07575672HFpEF - Heart Failure With Preserved Ejection Fraction, TAVI(Transcatheter Aortic Valve Implantation), Finerenone
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
2,832
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Zhengzhou
2026-07-01
Not yet open
Clinical Study of Traditional Chinese Medicine in the Treatment of Phlegm-dampness Intrinsic Precocious Puberty
NCT07637019Precocious Puberty
Children's Hospital of Fudan University
Not applicable
200
Xiamen, Guangzhou, Zhengzhou, Jinan, Shanghai
2026-07-01
Not yet open
Tegileridine for Postoperative Pain After Adolescent Scoliosis Surgery
NCT07229495Scoliosis; Adolescence, Pain After Surgery, Analgesia, Patient-controlled
Peking Union Medical College Hospital
Phase 4
171
Zhengzhou, Nanchang, Beijing, Shanghai
2026-07-01
Recruiting
A Study of Metformin to Improve Cardiac Function After LVAD Implantation
NCT07666698Heart Failure, Left Ventricular Assist Device
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
108
Nanjing, Hangzhou, Haโ€™erbin, Huai'an, Zhengzhou
2026-07-01
By invitation
Compassionate Administration of ZVS101e for Extended Treatment
NCT07307469Bietti Crystalline Corneoretinal Dystrophy
Chigenovo Co., Ltd
Not applicable
32
Beijing, Guangzhou, Zhengzhou, Chengdu, Tianjin
2026-07
Not yet open
A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer
NCT07653685Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1/2
71
Beijing, Lanzhou, Nanning, Zunyi, Harbin, Zhengzhou, Jingzhou, Wuhan
2026-07
Not yet open
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid Tumors
NCT07738679Advanced Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
127
Beijing, Lanzhou, Guangzhou, Anyang, Luoyang, Zhengzhou, Nanjing, Xuzhou
2026-07
Not yet open
Effects of Exercise Sequence and Meal Sequence on Weight Management Among Children and Adolescents With Overweight or Obesity: The STEP Trial
NCT07712068Obesity & Overweight, Insulin Resistance, Inflamation
Peking University
Not applicable
480
Wuhu, Zhengzhou, Shenyang, Zibo, Shanghai, Hangzhou, Jinhua, Beijing
2026-07
Not yet open
A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
NCT07595913Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3
240
Zhengzhou
2026-07
Not yet open
Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
NCT07695896Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Yanyan Liu
Observational
200
Zhengzhou
2026-07
Not yet open
Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy
NCT07684950Mantle Cell Lymphoma (MCL)
Henan Cancer Hospital
Phase 2
45
Zhengzhou
2026-06-30
Recruiting
Study of AHB-171 in Chronic Hepatitis B Participants
NCT07630727Hepatitis B, Chronic (CHB)
Ausper Biopharma Co., Ltd.
Phase 2
138
Beijing, Chongqing, Xiamen, Guangzhou, Nanning, Zhengzhou, Changzhou, Jilin City
2026-06-24
Recruiting
An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies
NCT07619287Myeloid Malignancy
BeOne Medicines
Phase 1
118
Lanzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Suzhou, Nanchang, Tianjin
2026-06-23
Recruiting
Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities
NCT07781124End Stage Renal Disease (ESRD), Chronic Kidney Disease (CKD)
Vantive Health LLC
Observational
750
Beijing, Chongqing, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Changsha
2026-06-17
Recruiting
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy
NCT07629817Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital
Phase 3
1,044
Zhengzhou
2026-06-16
Not yet open
A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
NCT07550842Small Cell Carcinoma of Lung
Shanghai Best-Link Bioscience, LLC
Phase 1
33
Harbin, Zhengzhou, Wuhan, Changzhou, Shenyang, Taizhou, Shanghai
2026-06-16
Recruiting
N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors
NCT07639450Advanced Malignant Solid Tumors
Hefei Xinzhu Biological Technology Co., Ltd.
Phase 1/2
114
Changsha, Shanghai, Zhengzhou
2026-06-15
Recruiting
A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07)
NCT07502300Extensive-stage Small-cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
562
Zhengzhou, Shanghai
2026-06-15
Not yet open
Zanubrutinib Induction Followed by Delayed Fixed-Duration Combination With Sonrotoclax for CLL/SLL๏ผšStop Trial 2.0
NCT07682415CLL / SLL
Yi Shuhua
Phase 2
60
Shenzhen, Zhengzhou, Changsha, Nanjing, Nanchang, Jinan, Tianjin
2026-06-08
Recruiting
A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
NCT07633301Narcolepsy Type 1
Takeda
Phase 2
92
Beijing, Guangzhou, Zhengzhou
2026-06-04
Not yet open
Pro-urokinase for Extended-Window Posterior Circulation Stroke
NCT07617870Acute Ischemic Stroke
The First Affiliated Hospital of Zhengzhou University
Phase 3
586
Zhengzhou
2026-06-01
Recruiting
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
NCT06712654Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis, End Stage Renal Disease on Dialysis
R1 Therapeutics
Phase 2
168
Beijing, Zhengzhou, Nanjing, Shanghai, Chengdu
2026-06-01
Not yet open
Spectral Precise Image Study for Coronary Artery
NCT07620457Cardiac
Philips Clinical & Medical Affairs Global
Observational
200
Zhengzhou
2026-06-01
Recruiting
Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients
NCT07663253Multiple Myeloma
Shanghai Zhongshan Hospital
Observational
333
Beijing, Guangzhou, Shenzhen, Naning, Harbin, Zhengzhou, Wuhan, Nanjing
2026-06
Not yet open
JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
NCT07582822Advanced Solid Tumor
Biotech Pharmaceutical Co., Ltd.
Phase 1
60
Chongqing, Zhengzhou, Changsha, Nanjing, Xi'an, Shanghai, Taiyuan, Chengdu
2026-05-30
By invitation
A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)
NCT07633197Herpes
Changchun BCHT Biotechnology Co.
Phase 1
120
Zhengzhou
2026-05-28
Recruiting
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
NCT06993506HER2-negative Breast Cancer, Recurrence, Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
500
Hefei, Beijing, Fuzhou, Xiamen, Shijiazhuang, Zhengzhou, Shiyan, Wuhan
2026-05-28
Recruiting
A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function
NCT07540754Diabetes Mellitus, Weight Loss
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 1
24
Zhengzhou
2026-05-26
Recruiting
Surface-Modified Flow Diverter for Intracranial Aneurysms: Assessment of Ischemic and Clinical Outcomes
NCT07674004Intracranial Aneurysms, Flow Diverter
Henan Provincial People's Hospital
Not applicable
196
Zhengzhou
2026-05-21
Recruiting
Chinese Adults With Kidney Disease
NCT07522099Immunoglobulin A Nephropathy (IgAN), Complement 3 Glomerulopathy (C3G), IC-MPGN
ADARx Pharmaceuticals, Inc.
Phase 2
30
Shenzhen, Guiyang, Zhengzhou, Baotou, Wuxi, Yantai, Beijing, Shandong
2026-05-21
Recruiting
A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC
NCT07547553Advanced or Unresectable Hepatocellular Carcinoma (HCC)
Huahui Health
Phase 1/2
30
Bengbu, Hefei, Beijing, Fuzhou, Guangzhou, Nanning, Harbin, Zhengzhou
2026-05-19
Not yet open
A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)
NCT07593144Advanced Solid Tumors
Foresight Therapeutics (Hefei) Co., Ltd.
Phase 1
156
Hefei, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanchang, Changchun
2026-05-15
Recruiting
A Phase โ…ก/โ…ข Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer
NCT07462143Colorectal (Colon or Rectal) Cancer
RemeGen Co., Ltd.
Phase 2/3
80
Beijing, Chongqing, Fuzhou, Meizhou, Nanjing, Shijiazhuang, Zhengzhou, Wuhan
2026-05-12
Active, closed
Iparomlimab and Tuvonralimab Injection (QL1706) Combined With DOS as Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction
NCT07776639Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
Yongxu Jia
Phase 2
34
Zhengzhou
2026-05-10
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
NCT07415031Solid Tumors
Mirati Therapeutics Inc.
Phase 2
170
Beijing, Xiamen, Zhengzhou, Changsha, Nanjing, Nanchang, Shenyang, Jinan
2026-05-06
Not yet open
Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction Cancer
NCT07610629Gastric Adenocarcinoma
Henan Cancer Hospital
Phase 2
50
Zhengzhou
2026-05-05
Not yet open
Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch
NCT07540416Acute Ischemic Stroke
The First Affiliated Hospital of Zhengzhou University
Phase 3
564
Zhengzhou
2026-05-01
Not yet open
X-ray Assisted Diagnostic System
NCT07497243Chest X-ray for Clinical Evaluation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
16,000
Wuhan, Zhengzhou
2026-05-01
Not yet open
Clinical Study on the Preservation of Ovarian Function in Patients With Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Goserelin
NCT07552506Aplastic Anaemia (AA), Allogeneic Haematopoietic Stem Cell Transplantation, Ovarian Insufficiency
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
132
Zhengzhou, Wuhan, Kunming, Hangzhou
2026-05-01
Not yet open
Clinical Study on the Preservation of Ovarian Function Following Autologous Hematopoietic Stem Cell Transplantation Using Goserelin
NCT07552493Ovarian Insufficiency, Autologous Hematopoietic Stem Cell Transplantation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
64
Zhengzhou, Wuhan, Kunming, Hangzhou
2026-05-01
Not yet open
UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma
NCT07500805CD70-positive Advanced Renal Clear Cell Carcinoma
UTC Therapeutics Inc.
Phase 1
21
Zhengzhou
2026-05-01
Not yet open
Clinical Study on the Preservation of Ovarian Function Following Hematopoietic Stem Cell Transplantation in Patients With Malignant Hematologic Diseases Using Goserelin
NCT07552480Allogeneic Haematopoietic Stem Cell Transplantation, Malignant Hematologic Disease, Ovarian Insufficiency
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
64
Zhengzhou, Wuhan, Kunming, Hangzhou
2026-05-01
Not yet open
Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT
NCT07550894Acute Kidney Injury, Sepsis, Critically Ill Patients Requiring Continuous Renal Replacement Therapy
Sun Yat-sen University
Phase 3
220
Chongqing, Guangzhou, Nanning, Luoyang, Zhengzhou, Wuhan, Nanjing, Xi'an
2026-05-01
Not yet open
Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis
NCT07566065Atherosclerotic Renal Artery Stenosis, Hypertension, Renal Artery Stenosis
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
150
Guangzhou, Harbin, Zhengzhou, Nanjing, Nanchang, Dalian, Jinan, Qingdao
2026-04-30
Rows per page Showing 1–100 of 921
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/zhengzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 921 of those studies with a site in Zhengzhou.

How many clinical trials are recruiting in Zhengzhou?

553 of the 921 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 163 have not yet opened recruitment, 191 are active but closed to new participants, and 14 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Zhengzhou), 921 studies
PhaseStudiesRecruitingShare
Phase 31977921.4%
Phase 219412221.1%
Not applicable1217413.1%
Observational1206913%
Phase 1/21199212.9%
Phase 11128212.2%
Phase 435163.8%
Phase 2/313101.4%
Phase EARLY_PHASE11091.1%

Most active sponsors

Lead sponsors with the most studies (Zhengzhou)
Lead sponsorStudiesRecruiting
Henan Cancer Hospital7247
The First Affiliated Hospital of Zhengzhou University3926
Merck Sharp & Dohme LLC2714
AbbVie218
Novartis Pharmaceuticals208
Bristol-Myers Squibb197
Henan University of Traditional Chinese Medicine184
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.158
BeOne Medicines1410
Henan Provincial People's Hospital147
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.